Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludwig Kappos

Showing results (11-20 of 603) with videos related to

Pageof 61
Sort By:
Handbook of Clinical Neurology|February 11, 2014
Clinical trials in multiple sclerosisGary Cutter, Ludwig Kappos
Neurodegenerative Disease Management|November 28, 2015
What is new in MS spasticity research? Poster session highlightsLudwig Kappos, Franz Fazekas
The New England Journal of Medicine|October 15, 2010
Images in clinical medicine. Dissociation of voluntary and emotional innervation after strokeLudwig Kappos, Matthias Mehling
Neurodegenerative Disease Management|November 28, 2015
2015 Multiple Sclerosis Experts SummitLudwig Kappos, Franz Fazekas
Neuro-Degenerative Diseases|December 14, 2007
Natalizumab: targeting alpha4-integrins in multiple sclerosisBritta Engelhardt, Ludwig Kappos
Brain : a Journal of Neurology|October 23, 2002
The Janus face of CNS-directed autoimmune response: a therapeutic challengeLudwig Kappos, Petra Duda
Annals of Neurology|October 3, 2009
Another complication of natalizumab treatment? Taking the challengeNorbert Goebels, Ludwig Kappos
Lancet (London, England)|November 7, 2012
Alemtuzumab for multiple sclerosis: who and when to treat?Till Sprenger, Ludwig Kappos
International MS Journal|February 24, 2004
Vancouver Consortium of MS Centers' Magnetic Resonance Imaging GuidelinesErnst-Wilhelm Radue, Ludwig Kappos
Journal of Neurology|September 20, 2005
10 years of interferon beta-1b (Beta feron therapyLudwig Kappos, Hans-Peter Hartung
Pageof 61

Showing results (11-20 of 603) with videos related to

Sort By:
Pageof 61
Handbook of Clinical Neurology|February 11, 2014
Clinical trials in multiple sclerosisGary Cutter, Ludwig Kappos
Neurodegenerative Disease Management|November 28, 2015
What is new in MS spasticity research? Poster session highlightsLudwig Kappos, Franz Fazekas
The New England Journal of Medicine|October 15, 2010
Images in clinical medicine. Dissociation of voluntary and emotional innervation after strokeLudwig Kappos, Matthias Mehling
Neurodegenerative Disease Management|November 28, 2015
2015 Multiple Sclerosis Experts SummitLudwig Kappos, Franz Fazekas
Neuro-Degenerative Diseases|December 14, 2007
Natalizumab: targeting alpha4-integrins in multiple sclerosisBritta Engelhardt, Ludwig Kappos
Brain : a Journal of Neurology|October 23, 2002
The Janus face of CNS-directed autoimmune response: a therapeutic challengeLudwig Kappos, Petra Duda
Annals of Neurology|October 3, 2009
Another complication of natalizumab treatment? Taking the challengeNorbert Goebels, Ludwig Kappos
Lancet (London, England)|November 7, 2012
Alemtuzumab for multiple sclerosis: who and when to treat?Till Sprenger, Ludwig Kappos
International MS Journal|February 24, 2004
Vancouver Consortium of MS Centers' Magnetic Resonance Imaging GuidelinesErnst-Wilhelm Radue, Ludwig Kappos
Journal of Neurology|September 20, 2005
10 years of interferon beta-1b (Beta feron therapyLudwig Kappos, Hans-Peter Hartung
Pageof 61